Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy
Primary Purpose
Autonomic Nervous System Imbalance, Psychological Distress, Cancer-related Pain
Status
Unknown status
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Andullation
Placebo
Sponsored by
About this trial
This is an interventional prevention trial for Autonomic Nervous System Imbalance
Eligibility Criteria
Inclusion Criteria:
- Histological proven breast cancer, following breast cancer surgery
- Starting with adjuvant radiation therapy for 3 weeks
- Minimum 18 years
- Medical record available and complete
- Supine lying on mattress for 20 minutes is possible
- Dutch, French or English
Exclusion Criteria:
- Severe neurological, orthopaedic or rheumatic disorders
- Cardiac disorders
- Early or synchronous malignancy
- Pregnancy or lactation
- Persons suffering from depression or illnesses which influence the mental health or wellbeing
Sites / Locations
- Universitair Ziekenhuis BrusselRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Intervention
Control
Arm Description
A 3 week intervention with Andullation will be performed, 3 times a week for 20 minutes after completion of the radiotherapy session
This group will follow the same intervention protocol, but without the application of the Andullation technology
Outcomes
Primary Outcome Measures
change in Heart Rate Variability (HRV)
a marker of the activity of your autonomic nervous system.
Secondary Outcome Measures
change in Distress Thermometer
A questionnaire to evaluate in what extent you experience complaints like distress and anxiety, on a visual thermometer. By encircling the number most applicable for your situation, we can estimate how you are feeling at the moment. The scale ranges from 0-10 where 0 indicates a better and 10 indicates a worse outcome.
change in Brief Pain Inventory
This questionnaire was designed to investigate the extent of pain you experience as well as to examine the influence of it on your quality of life. The BPI includes four ratings of pain intensity (items 3-7), and seven other ratings on the impact of pain. Intensity is recorded on numerical scales from zero (no pain) to ten (pain as bad as you can imagine). Also, intensity is rated at the time of completing the questionnaires (pain now) as well as its worst, least, and average over the past day or week.
change in Numeric Pain Rating Scale
An 11-point scale for patient self-reporting of pain. The scale ranges from 0-10 where 0 indicates a better and 10 indicates a worse outcome.
change in Perometer results
A device measuring your arm circumferences with the use of infrared light. It is an efficient, safe, painless and reliable method to examine your arm circumferences.
change in Bioimpedance spectroscopy
By using bioimpedance, we will estimate your body fat, water and muscle content. You will stand on scale and hold on to a handgrip that is connected with the scale. A small current will determine your body composition. This is a painless and innocuous examination.
change in European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire (EORTC QLQ C-30)
A questionnaire designed to investigate the quality of life in cancer patients. The questionnaire assesses some domains of your quality of life that can possibly be influenced by your disease. The questionnaire consists of 3 different scales: Global Health Status (GHS), Functional Scale (FS) and Symptom Scale (SS). The answers of the FS and SS are scored on a Likert scale where lower scores indicate better outcomes.The GHS differs from the other scales by scoring on a 7-point Likert scale where lower scores display worse outcomes.
change in European Organization for Research and Treatment of Cancer 23-item quality of life questionnaire (EORTC QLQ BR23)
A questionnaire designed to investigate the quality of life in breast cancer patients. The questionnaire assesses some domains of your quality of life that can possibly be influenced by your disease. It consists of 23 questions to determine body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy side effects, breast symptoms, arm symptoms and upset by hair loss assessed on a 4 point Likert scale where lower scores indicate better outcomes.
change in Pittsburgh Sleep Quality Index
A questionnaire that assesses your sleep quality, your sleep quantity and your sleep disturbance. The scale ranges from 0-21 where lower scores indicate better outcomes
change in Insomnia Severity Index
A questionnaire that assesses the severity, the nature and the impact of your insomnia over the past 2 - 4 weeks. The scale ranges from 0-28 where lower scores indicate better outcomes.
Full Information
NCT ID
NCT04125953
First Posted
June 24, 2019
Last Updated
October 11, 2019
Sponsor
Universitair Ziekenhuis Brussel
1. Study Identification
Unique Protocol Identification Number
NCT04125953
Brief Title
Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy
Official Title
The Influence of Stochastic Modulated Vibrations on the Autonomic Nervous System of Breast Cancer Patients During Radiotherapy: a Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
July 4, 2019 (Actual)
Primary Completion Date
September 30, 2020 (Anticipated)
Study Completion Date
October 31, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitair Ziekenhuis Brussel
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this research is to study the influence of stochastic modulated vibrations on the autonomic nervous system of breast cancer patients during radiation therapy
Detailed Description
Since it is well known that breast cancer patients experience an important load of stress from diagnosis through treatment and throughout cancer survivorship (fear of cancer recurrence), this study focusses on activation the parasympathetic nervous system and making patients as comfortable as possible during treatment. The scope of this study is based on previous research, that has shown that controlling physical and psychological complications during treatment may have a positive (preventive) effect on late term and long-term quality of life and survival outcomes. Breast cancer patients will receive andullation during their irradiation period. The primary outcome measure of the autonomic nervous system is vagal nerve activity, a modulator of the parasympathetic nervous system. Secondary outcome measures are stress, pain and lymphedema.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autonomic Nervous System Imbalance, Psychological Distress, Cancer-related Pain, Breast Cancer Lymphedema, Quality of Life
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized clinical trial
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
A 3 week intervention with Andullation will be performed, 3 times a week for 20 minutes after completion of the radiotherapy session
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
This group will follow the same intervention protocol, but without the application of the Andullation technology
Intervention Type
Device
Intervention Name(s)
Andullation
Intervention Description
Andullation is a horizontal vibration technique with stochastically modulated vibrations, build-in in a mattress.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Placebo Andullation
Primary Outcome Measure Information:
Title
change in Heart Rate Variability (HRV)
Description
a marker of the activity of your autonomic nervous system.
Time Frame
through study completion, an average of 6 weeks
Secondary Outcome Measure Information:
Title
change in Distress Thermometer
Description
A questionnaire to evaluate in what extent you experience complaints like distress and anxiety, on a visual thermometer. By encircling the number most applicable for your situation, we can estimate how you are feeling at the moment. The scale ranges from 0-10 where 0 indicates a better and 10 indicates a worse outcome.
Time Frame
through study completion, an average of 6 weeks
Title
change in Brief Pain Inventory
Description
This questionnaire was designed to investigate the extent of pain you experience as well as to examine the influence of it on your quality of life. The BPI includes four ratings of pain intensity (items 3-7), and seven other ratings on the impact of pain. Intensity is recorded on numerical scales from zero (no pain) to ten (pain as bad as you can imagine). Also, intensity is rated at the time of completing the questionnaires (pain now) as well as its worst, least, and average over the past day or week.
Time Frame
through study completion, an average of 6 weeks
Title
change in Numeric Pain Rating Scale
Description
An 11-point scale for patient self-reporting of pain. The scale ranges from 0-10 where 0 indicates a better and 10 indicates a worse outcome.
Time Frame
through study completion, an average of 6 weeks
Title
change in Perometer results
Description
A device measuring your arm circumferences with the use of infrared light. It is an efficient, safe, painless and reliable method to examine your arm circumferences.
Time Frame
through study completion, an average of 6 weeks
Title
change in Bioimpedance spectroscopy
Description
By using bioimpedance, we will estimate your body fat, water and muscle content. You will stand on scale and hold on to a handgrip that is connected with the scale. A small current will determine your body composition. This is a painless and innocuous examination.
Time Frame
through study completion, an average of 6 weeks
Title
change in European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire (EORTC QLQ C-30)
Description
A questionnaire designed to investigate the quality of life in cancer patients. The questionnaire assesses some domains of your quality of life that can possibly be influenced by your disease. The questionnaire consists of 3 different scales: Global Health Status (GHS), Functional Scale (FS) and Symptom Scale (SS). The answers of the FS and SS are scored on a Likert scale where lower scores indicate better outcomes.The GHS differs from the other scales by scoring on a 7-point Likert scale where lower scores display worse outcomes.
Time Frame
through study completion, an average of 6 weeks
Title
change in European Organization for Research and Treatment of Cancer 23-item quality of life questionnaire (EORTC QLQ BR23)
Description
A questionnaire designed to investigate the quality of life in breast cancer patients. The questionnaire assesses some domains of your quality of life that can possibly be influenced by your disease. It consists of 23 questions to determine body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy side effects, breast symptoms, arm symptoms and upset by hair loss assessed on a 4 point Likert scale where lower scores indicate better outcomes.
Time Frame
through study completion, an average of 6 weeks
Title
change in Pittsburgh Sleep Quality Index
Description
A questionnaire that assesses your sleep quality, your sleep quantity and your sleep disturbance. The scale ranges from 0-21 where lower scores indicate better outcomes
Time Frame
through study completion, an average of 6 weeks
Title
change in Insomnia Severity Index
Description
A questionnaire that assesses the severity, the nature and the impact of your insomnia over the past 2 - 4 weeks. The scale ranges from 0-28 where lower scores indicate better outcomes.
Time Frame
through study completion, an average of 6 weeks
10. Eligibility
Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Histological proven breast cancer, following breast cancer surgery
Starting with adjuvant radiation therapy for 3 weeks
Minimum 18 years
Medical record available and complete
Supine lying on mattress for 20 minutes is possible
Dutch, French or English
Exclusion Criteria:
Severe neurological, orthopaedic or rheumatic disorders
Cardiac disorders
Early or synchronous malignancy
Pregnancy or lactation
Persons suffering from depression or illnesses which influence the mental health or wellbeing
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nele Adriaenssens, Prof. Dr.
Phone
00324763623
Email
nele.adriaenssens@vub.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nele Adriaenssens, Prof. Dr.
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitair Ziekenhuis Brussel
City
Jette
State/Province
Brussels
ZIP/Postal Code
1090
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nele Adriaenssens, prof. dr.
Phone
024763623
Ext
0032
Email
nele.adriaenssens@uzbrussel.be
First Name & Middle Initial & Last Name & Degree
Ellen Vandyck, dra.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy
We'll reach out to this number within 24 hrs